A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant

Pan‐Chyr Yang(Institute of Biomedical Sciences, Academia Sinica), Tein-Yao Chang(National Defense Medical Center), Hsuan-ying Lu(National Defense Medical Center), Fang‐Yu Chang, Sui‐Yuan Chang(National Taiwan University of Science and Technology), Han‐Chieh Kao(National Taiwan University), Tong‐Young Lee(Viva Biotech (China)), Ya‐Min Tsai(National Taiwan University), Yuan‐Fan Chin(National Defense Medical Center), Si‐Man Ieong(National Taiwan University), Shu‐Chen Hsu(National Defense Medical Center), Yi‐Fen Chen, Chia‐Chun Yang(Viva Biotech (China)), Hung‐Wen Chou, Ren‐Shiuan Weng, Jun‐Tung Fang(National Taiwan University), Ping‐Cheng Liu(National Defense Medical Center), Tai‐Ling Chao(National Taiwan University), Yuan‐Lin Chou(Viva Biotech (China)), Jia‐Yu Chang(National Defense Medical Center), Kuo‐Yen Huang(National Defense Medical Center), Qian‐Wen Tu, Chi‐Fan Yang(Viva Biotech (China))
EMBO Molecular Medicine
February 8, 2022
Cited by 66


Related Papers